MY192792A - A composition of multivalent pneumococcal capsular polysaccharide-carrier protein conjugates and use thereof - Google Patents

A composition of multivalent pneumococcal capsular polysaccharide-carrier protein conjugates and use thereof

Info

Publication number
MY192792A
MY192792A MYPI2019001207A MYPI2019001207A MY192792A MY 192792 A MY192792 A MY 192792A MY PI2019001207 A MYPI2019001207 A MY PI2019001207A MY PI2019001207 A MYPI2019001207 A MY PI2019001207A MY 192792 A MY192792 A MY 192792A
Authority
MY
Malaysia
Prior art keywords
carrier protein
capsular polysaccharide
composition
protein conjugates
pneumococcal capsular
Prior art date
Application number
MYPI2019001207A
Other languages
English (en)
Inventor
Tae Hyun Kim
Hoon Sung Jeh
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of MY192792A publication Critical patent/MY192792A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
MYPI2019001207A 2016-09-06 2017-08-31 A composition of multivalent pneumococcal capsular polysaccharide-carrier protein conjugates and use thereof MY192792A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160114591 2016-09-06
PCT/KR2017/009569 WO2018048141A1 (fr) 2016-09-06 2017-08-31 Composition comprenant une protéine multivalent de transport de polysaccharide capsulaire et son utilisation

Publications (1)

Publication Number Publication Date
MY192792A true MY192792A (en) 2022-09-09

Family

ID=61561397

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2019001207A MY192792A (en) 2016-09-06 2017-08-31 A composition of multivalent pneumococcal capsular polysaccharide-carrier protein conjugates and use thereof

Country Status (12)

Country Link
KR (1) KR101991457B1 (fr)
BR (1) BR112019004303A2 (fr)
EA (1) EA201990451A1 (fr)
JO (1) JOP20190038B1 (fr)
MA (1) MA45283B1 (fr)
MX (1) MX2019002552A (fr)
MY (1) MY192792A (fr)
PH (1) PH12019500377B1 (fr)
SA (1) SA519401232B1 (fr)
TN (1) TN2019000064A1 (fr)
WO (1) WO2018048141A1 (fr)
ZA (1) ZA201901969B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210177957A1 (en) 2017-12-06 2021-06-17 Merck Sharp & Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
KR102486891B1 (ko) 2018-02-05 2023-01-10 사노피 파스퇴르 인코포레이티드 다가 폐렴구균성 다당류-단백질 접합체 조성물
KR20190121713A (ko) * 2018-04-18 2019-10-28 에스케이바이오사이언스(주) 스트렙토코커스 뉴모니애 협막 다당류 및 그의 면역원성 접합체
KR20240169145A (ko) 2018-12-19 2024-12-02 머크 샤프 앤드 돔 엘엘씨 스트렙토코쿠스 뉴모니아에 폴리사카라이드-단백질 접합체를 포함하는 조성물 및 그의 사용 방법
CN119317445A (zh) * 2022-05-11 2025-01-14 辉瑞公司 用于生产含有防腐剂的疫苗制剂的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69433341T2 (de) * 1993-09-22 2004-04-15 Henry M. Jackson Foundation For The Advancement Of Military Medicine Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
KR102378962B1 (ko) * 2005-04-08 2022-03-28 와이어쓰 엘엘씨 다가 폐렴구균 다당류-단백질 접합체 조성물
EP3170508B1 (fr) * 2010-06-04 2019-11-13 Wyeth LLC Formulations vaccinales
KR102057217B1 (ko) * 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
CN103893751B (zh) * 2014-03-26 2016-04-20 天津康希诺生物技术有限公司 一种肺炎球菌多糖蛋白缀合疫苗及其制备方法
CN104069504B (zh) * 2014-05-11 2019-09-24 江苏康泰生物医学技术有限公司 一种增强多糖蛋白结合物免疫原性的方法

Also Published As

Publication number Publication date
SA519401232B1 (ar) 2022-10-23
MA45283B1 (fr) 2021-05-31
KR101991457B1 (ko) 2019-09-30
EA201990451A1 (ru) 2019-08-30
PH12019500377A1 (en) 2019-10-21
TN2019000064A1 (en) 2020-07-15
JOP20190038B1 (ar) 2023-09-17
PH12019500377B1 (en) 2024-05-15
MX2019002552A (es) 2019-07-01
JOP20190038A1 (ar) 2019-03-06
BR112019004303A2 (pt) 2019-05-28
MA45283A1 (fr) 2019-06-28
KR20180027353A (ko) 2018-03-14
ZA201901969B (en) 2019-12-18
WO2018048141A1 (fr) 2018-03-15

Similar Documents

Publication Publication Date Title
PH12021550318A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
IL265623A (en) Multivalent vaccines for pneumonia that include polysaccharide-protein conjugates
MX382438B (es) Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos
ZA201903620B (en) Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
MX2020002556A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
MX371453B (es) Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos.
MX2020002555A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
MY192792A (en) A composition of multivalent pneumococcal capsular polysaccharide-carrier protein conjugates and use thereof
MX2021014948A (es) Metodos de tratamiento de pacientes con una composicion inmunogenica que protege contra el seroripo 29 de s. pneumoniae.
MX2016003621A (es) Vacunas sinteticas libres de proteina y peptido contra streptococcus pneumoniae tipo 3.
ZA202103560B (en) Multivalent pneumococcal polysaccharide-protein conjugate vaccine
IL276661B1 (en) Immunogenic preparation containing staphylococcal antigens
PH12018501205A1 (en) Synthetic vaccines against streptococcus pneumoniae serotype 2
TH1701007335A (th) วิธีการสำหรับการปรับปรุงการดูดซับของคอนจูเกตโพลีแซคคาไรด์-โปรตีน และ สูตรตำรับมัลติวาเลนท์วัคซีนที่ถูกได้มาจากสิ่งนั้น